ClinicalTrials.Veeva

Menu

The Papillary Muscle Approximation Provide Stability of Mitral Valve Repair for Ischemic Mitral Regurgitation (PMA)

T

The Federal Centre of Cardiovascular Surgery, Russia

Status

Unknown

Conditions

Mitral Regurgitation

Treatments

Procedure: The papillary muscle approximation

Study type

Observational

Funder types

Other

Identifiers

NCT03038204
FederalCCS 001

Details and patient eligibility

About

Recent publications show that an adjunctive subvalvular repair during mitral annuloplasty for secondary mitral regurgitation effective in preventing recurrent regurgitation. One of these procedures is the papillary muscles approximation. However, the safety and the positive impact of this method are still in doubt.

Full description

Ischemic mitral regurgitation develops in 10-50% of patients after myocardial infarction. Among several surgical procedures, mitral ring annuloplasty has been the method of choice for a considerable period. However, mitral regurgitation recurrence after surgery has a reported occurrence that ranges from 5% to 58%. Careful consideration of the mechanisms underlying recurrence of mitral regurgitation after annuloplasty might explain the unsatisfactory outcomes. The pathophysiology of IMR is complex and results from the imbalance between closing and tethering forces acting on the mitral valve. Enlargement of the left ventricular chamber, and displacement of papillary muscles in apical and lateral direction increase the tethering forces. Left ventricular and papillary muscle dyssynchrony, reduced myocardial contractility decrease closing forces, which lead to impaired leaflet coaptation and appearance of mitral regurgitation. Thus, treatment of mitral insufficiency requires an integrated approach affecting all units of the pathogenesis of MR recurrence.

Recent publications show that an adjunctive subvalvular repair during mitral annuloplasty for secondary mitral regurgitation effective in preventing recurrent regurgitation. One of these procedures is the papillary muscles approximation. However, the safety and the positive impact of this method are still in doubt. This study is conducted to identify the positive qualities and safety of this technique.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ischemic cardiomyopathy,
  • Ischemic mitral regurgitation.

Exclusion criteria

  • Degenerative mitral valve disease,
  • Unstable angina,
  • Recent myocardial infarction (< 6 months),
  • Papillary muscles rupture,
  • Severe right ventricular dysfunction,
  • Multiple organ failures,
  • Concomitant left ventricular reconstruction,
  • Aortic valve procedures.

Trial design

100 participants in 2 patient groups

PMA+MVA+CABG
Description:
patients with ischemic cardiomyopathy and mitral regurgitation who underwent coronary artery bypass grafting, mitral annuloplasty, and papillary muscles approximation.
Treatment:
Procedure: The papillary muscle approximation
MVA+CABG
Description:
patients with ischemic cardiomyopathy who underwent coronary artery bypass grafting and mitral valve annuloplasty.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems